Guggenheim Capital’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $811K | Sell |
30,615
-243
| -0.8% | -$6.44K | 0.01% | 963 |
|
|
2025
Q1 | $745K | Buy |
30,858
+5,519
| +22% | +$133K | 0.01% | 1013 |
|
|
2024
Q4 | $1.02M | Buy |
25,339
+142
| +0.6% | +$5.71K | 0.01% | 909 |
|
|
2024
Q3 | $1.6M | Sell |
25,197
-2,613
| -9% | -$165K | 0.01% | 897 |
|
|
2024
Q2 | $1.47M | Buy |
+27,810
| New | +$1.47M | 0.01% | 929 |
|
|
2018
Q2 | – | Sell |
-11,988
| Closed | -$52K | – | 2611 |
|
|
2018
Q1 | $52K | Buy |
+11,988
| New | +$52K | ﹤0.01% | 2706 |
|
|
2017
Q4 | – | Sell |
-10,366
| Closed | -$20K | – | 2814 |
|
|
2017
Q3 | $20K | Buy |
+10,366
| New | +$20K | ﹤0.01% | 2746 |
|